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A B S T R A C T
Immunological responses to invading bacteria play a major role in the course of in-
flammatory periodontal diseases, such as CP. It was suggested that one of the major ele-
ments in determining the course of the disease is the expression of cellular adhesion mo-
lecules. We therefore investigated the expression of cellular adhesion molecules, ICAM-1
and beta-1 integrins, capillary density and lymphocyte subpopulations in gingival biop-
sies obtained from 20 patients with CP who responded and 21 patient who failed to res-
pond to initial treatment using immunohistochemical methods. We found no differences
between the two groups in capillary density, ICAM-1 and beta-1 integrin expression. Pa-
tients who responded to treatment had a lymphocytic inflammatory infiltrate consisting
predominantly of T cells, while those who failed to respond had an approximately equal
number of T and B cells. Our findings support the role of host immunological mecha-
nisms in determining the outcome of CP and argue against a major role of differential
cellular adhesion molecule expression.
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Introduction
Chronic periodontitis (CP) is a chronic
inflammatory periodontal disease charac-
terised by gingival inflamation, forma-
tion of periodontal pockets and alveolar
bone resorption. It is continuously prog-
ressive with brief episodes of localized ex-
acerbations and occasional remissions.
Dental plaque bacteria trigger the in-
flammatory response of host defence me-
cahnisms that ultimately lead to tissue
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destruction1. Treatment of CP includes
measures designed to eliminate or control
plaque infection in combination with re-
moval of plaque retention factors.
Components of microbial plaque have
the capacity to induce the initial infiltra-
te of inflammatory cells including lym-
phocytes, macrophages and polymorpho-
nuclear granulocytes (PMNs) in CP2,3.
Homing and retention of lymphocytes is
dependent upon the expression of adhe-
sion molecules4,5. Intercellular adhesion
molecule-1 (ICAM-1) is involved in the
accumulation and activation of leuko-
cytes in inflammatory sites through bind-
ing to beta-1 integrins expressed on leu-
kocytes6,7. Beta-1 integrins are adhesion
molecules that appear on lymphocytes af-
ter activation and bind to the extracellu-
lar matrix, specifically collagen, laminin
and fibronectin. PMN accumulation and
activity in the gingival crevice results in
relase of enzymes that have detrimental
effects on bateria as well as on host tis-
sue8,9. Many cells within the inflammato-
ry cell infiltrate produce matrix degrad-
ing enzymes and cytokines that directly
and indirectly further degrade the con-
nective tissue and bone.
Some10–13, but not all authors14–16 ha-
ve found an increase in ICAM-1 expres-
sion in gingiva of patients with more se-
vere inflammatory periodontal dieases.
One group has found an increase in be-
ta-1 integrin (also called VLA) expression
in the gingival tissue of patients with pe-
riodontitis17,18. Also, differences were fou-
nd in lymphocyte subpopulations infiltra-
ting gingival tissues in patients with
severe and mild types of inflammatory
periodontal diseases.
However, it is unknown whether pa-
tients who respond differently to initial
therapy show differences in characteristics
of gingival inflammatory cell inflitrates,
specifically lymphocytes and/or differen-
ces in expression of ICAM-1 and beta-1
integrins on gingival tissue and infiltrat-
ing inflammatory cells. To answer this
question we have studied the expression
of ICAM-1 and beta-1 integrins, capillary
density and T and B lymphocyte infiltra-
tion in gingival biopsies obtained from
patients with CP who responded to or fai-
led to respond to initial periodontal ther-
apy.
Subjects and methods
The study was performed in a group of
41 patients with CP at the time of reevalu-
ation after initial therapy, i.e. three mon-
ths after the start of treatment. Twenty
patients responded favorably while 21
failed to respond to initial treatment.
There were 31 males and 10 females,
30–60 years of age. Inclusion criteria were
at least 20 permanent teeth remaining,
adequately restored and without signs of
active caries as determined by radiog-
raphs and clinical inspection, probing
depths more than 5 mm on at least 6
teeth in three different quadrants and ra-
diographically visible alveolar bone loss.
Excluded from the study were patients
with inadequate oral hygiene despite gi-
ven repeated instructions in oral hygiene,
with serious systemic diseases such as di-
abetes and cancer, or which have taken
antibiotics 6 months prior to start of the
study. All patients participating gave
written informed consent for this study.
Standard initial periodontal examina-
tion was performed in all patients prior to
the initial therapy including determina-
tion of bleeding on probing, probing depth
measured on 6 sites per tooth, furcation
involvements, tooth mobility and radiog-
raphy. Initial treatment consisted of in-
structions in oral hygiene, removal of lo-
cal irritations and subgingival root de-
bridement. Scaling and root planing was
performed quadrantwise under local an-
esthesia using Gracey curettes and sonic
scalers by one trained periodontist. The
periodontal examination was repeated af-
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ter three months. Patients were conside-
red to have favorably responded if they
had less than 15% sites positive for bleed-
ing on probing and their mean pocket
depth was reduced by 1.5 mm or more.
Biopsies of gingival tissue, approxima-
tely 3 mm wide, were obtained during
therapeutic periodontal surgery procedu-
res under local anesthesia, that were un-
dertaken as a part of the corrective phase
of the periodontal treatment. Biopsies
were taken from interproximal sites of
teeth with deepest probing depth values
in the surgical area. The tissue samples
were instantly frozen in liquid nitrogen
and stored at –20 °C. All samples were
analyzed using standard histological he-
malaun-eosin (HE) staining and immu-
nohistochemical technics. The latter were
performed using murine monoclonal anti-
bodies directed against the T cell marker
CD3, B cell marker CD20 (Boehringer,
Ingelheim, Germany), endothelial cell
marker von Willebrand factor, ICAM-1
(DAKO Cytomation, Glostrup, Denmark)
and beta-1 intergin (Mario Negri, Milano,
Italy). Primary antibodies were detected
using biotynilated anti-murine secondary
antibodies (DAKO) and the avidin-biotin
peroxidase (Vector, Burlingame, Ca, USA).
Lymphocytic infiltrates were semiqu-
antitatively graded and divided into three
groups:
1) predominantly T cells
2) similar numbers of B and T cells
3) predominantly B cells.
Capillary density was determined as
follows. Tissue sections were examined
under low magnification (40 and 100).
Three hot-spots, with a large number of
vessels were identified. These hot-spots
were analyzed using higher maginifica-
tion (200). In each of them vessels were
counted in an area of 0.785 mm2. Results
were expressed as the highest count (maxi-
mal vessel density) and the average of the
three counts (average vessel density).
Expression of ICAM-1 and beta-1 integ-
rins was determined in gingival epitelium.
In case of beta-1 integrins, a distinction
was made between basal and subbasal ex-
pression. Expression was graded qualita-
tively as present or absent.
Statistical analysis was performed us-
ing »Statistica for Windows 4.0« software,
and the Chi-square test was used to des-
cribe differences between groups.
Results
In the group of patients who favour-
ably responded, the mean probing depth
before the therapy was 3.8±0.9 mm, and
after the therapy 2.2±0.6 mm. In the group
of patients who did not respond to thera-
py, initial mean probing depth was 3.9±
1.0 mm, and 3.3±0.7 mm after the reeval-
uation. Inflammation was present in all
gingival samples analyzed, as determi-
ned by the presence of inflammatory mo-
nonuclear cell infiltrate.
The ratio of T to B lymphocytes was
higher in gingival inflammatory patients
who responded to treatment than in tho-
se who did not (Fig. 1). In the former
group 11 patients had predominantly T
cells, 4 similar number of T and B cells
and 4 predominantly B cells in their gin-
gival biopsies (Fig. 1). In one patient the
quality of the bioptic material was insuf-
ficient for the analysis. In the group of pa-
tients who failed initial treatment 4 had
predominantly T cells, 11 similar num-
bers of T and B cells (Fig. 2) and 6 predo-
minantly B cells in their gingival biopsies.
This difference is statistically significant
(p=0.033, 2=6.850).
Results of other immunohistochemical
analyses are presented in Table 1. Pa-
tients who did and did not respond to ini-
tial therapy had similar capillary density,
ICAM-1 expression (Figures 3a, 3b) and
basal and subbasal beta-1 integrin ex-
pression (Figures 4a, 4b).
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Discussion
Treatment of inflammatory periodon-
tal disorders is frequently unsatisfactory
and ultimately results in tooth loss. Mo-
dern periodontological research therefore
focuses on investigations of molecular and
cellular mechanisms in the hope that this
will lead to changes in diagnostic approac-
hes or treatment by blocking or modulat-
ing these mechanisms. Some authors19,20
actually suggest that blocking ICAM-1
might be an effective treatment for other-
wise refractory cases of periodontitis.
In some of the previous studies differ-
ences in ICAM-1 and beta-1 integrin ex-
pression were found to be related to the
degree of gingival inflammation or type of
periodontal disease (periodontitis vs. gin-
givitis)11,13,17. We therefore speculated
that the same might be true for patients
with CP who respond or fail to respond to
initial treatment. However, in this study
we found no indications that the differen-
ces in response to initial treatment in CP
are related to differences in expression of
intercellular adhesion molecules on gin-
gival tissue or infiltrating inflammatory
cells. Our results therefore seem to be in
accordance with earlier studies that found
no differences in ICAM-1 expression in
gingival tissue of periodontally healthy
persons in comparison to patients with
inflammatory periodontal disease and
contradict those who found a difference
15,21. However, this might not be com-
pletely true since inflammation in our
study was present in all analyzed sam-
ples and the degree of inflammation did
not correlate with the clinical response.
The reason for this discrepancy lies prob-
ably in the fact that in periodontal disor-
ders the important pathologic processes
take place in deep supportive tissues and
not on the surface. Therefore changes
seen in the biopsies of epithelial and su-
perficial supportive tissues probably do
not correlate very well with the disease
course. Still, our data suggest that the ex-
pression of cellular adhesion molecules in
the gingiva of patients with CP does not
affect the disease course.
The clinical response to initial treat-
ment correlated with a lymphocytic inflam-
matory infiltrate that consisted mainly of
T cells. T cells have various functions,
they can act as cytotoxic killer cells or
cells that regulate the inflammatory res-
ponse. Specific subsets of T cells can stim-
ulate the inflammatory response but also
suppress it. Th1 T lymphocytes stimulate
cellular immunity, while Th2 T lympho-
cytes stimulate humoral immunity and
counteract some of the Th1 mediated ef-
fects22,23. On the other hand, B cells secre-
te immunoglobulins and act as antigen
presenting cells. Secretion of immunoglo-
bulins in the gingiva would cause an in-
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T = predominantly T lymphocytes
T+B = similar numbers of T and B lymphocytes
B = predominantly B lymphocytes
Fig. 1. Distribution of lymphocytic infiltrates in
gingival biopsies of subjects after initial perio-
dontal therapy.
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Fig. 2. Gingival biopsy from a non-responding patient. The gingival surface is covered with
hyperplastic epithelium. An inflammatory infiltrate consisting of similar numbers of T- (CD3
positive cells- Fig. 1a) and somewhat more superficially located B-lymphocytes (CD20 positive
cells- Fig. 1b) can be seen. Magnification 40.
TABLE 1
RESULTS OF IMMUNOHISTOCHEMICAL ANALYSES
Subject Responders Non-responders
Capillary density (medium/minimal-maximal) 23/9-45 29/11-25
ICAM-1 expression positive expression (N/%) 8/40% 9/43%
Subbasal beta-1 integrin expression positive
expression (N/%)
9/45% 11/52%















crease in migration of PMNs and other
phagocytes, thereby increasing local in-
flammatory activity24,25. The antigen pre-
senting activity of B cells would also in
the end augment the inflammatory res-
ponse. Since tissue destruction in CP, as
in other, more severe types of periodonti-
tis, is ultimately caused by host defence
mechanisms and not by microbes, it is
conceivable that patients who fail initial
periodontal therapy have an inappropria-
tely increased local inflammatory res-
ponse. Alternatively, an effective cellular
immune response, mediated by Th1 T
lymphocytes could lead to a fast sanation
of the primary pathogenic process, while
a response involving Th2 T lymphocytes
that stimulate the accumulation of B cells
and immunoglobulin secretion might be
less effective in dealing with the factors
triggering CP. To distinguish between
these possibilities it would be necessary
to further characterize T cell infiltrates in
both groups of patients.
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Fig. 3. Two gingival biopsy specimens from responding patients. Fig. 3a shows strong














The expression of adhesion molecules
ICAM-1 and beta-1 integrins in gingival
biopsies of patients with CP who respond
or fail to respond to initial periodontal
treatment is similar. This argues against
the importance of these molecules in the
modulation of the disease course.
Patients with CP who respond to ini-
tial treatment have a lymphocytic inflam-
matory infiltrate in the gingiva consisting
predominantly of T cells, while in those
who fail treatment approximately equal
numbers of T and B cells are found. This
finding supports the thesis that the diffe-
rences in immunological response of the
host are most important in determining
the disease course.
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Fig. 4. Two gingival biopsy specimens from non-responding patients stained for beta-1
integrin with positive expression. In Fig. 4a positive cells are located in the basal, and in
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SUBPOPULACIJA LIMFOCITA I EKSPRESIJA INTERCELULARNIH
ADHEZIJSKIH MOLEKULA U KRONI^NOM PERIODONTITISU
S A @ E T A K
Imunolo{ki odgovor na invazivne bakterije ima glavnu ulogu u upalnim bolestima
periodonta, kao {to je kroni~ni periodontitis (CP). Predlo`eno je da je jedan od glavnih
elemenata te bolesti ekspresija adhezivnih molekula. Kori{tenjem imunohistokemij-
skih metoda istra`ili smo ekspresiju adhezivnih molekula ICAM-1 i ß1-integrina, te
kapilarnu gusto}u i subpopulacije limfocita iz gingivalnih biopsija dobivenih od 20 pa-
cijenata s CP koji su reagirali na terapiju i 21 pacijenta koji nisu reagirali na terapiju.
Izme|u te dvije grupe nismo prona{li nikakvu razliku u ekspresiji ICAM-1 i ß1-inte-
grina. Pacijenti koji su reagirali na terapiju pokazivali su uglavnom T limfocitni infil-
trat, dok su oni koji nisu reagirali na terapiju pokazivali jednaki broj T i B limfocita.
Ovi nalazi podupiru ulogu imunolo{kih mehanizama koji odre|uju CP i govore protiv
centralne uloge adhezivnih molekula.
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